William N Doyle
Papers
1
Total Citations
2
H-Index
1
About
William N. Doyle is a clinical researcher specializing in thoracic surgical oncology, with a particular focus on optimizing outcomes for lung cancer patients undergoing minimally invasive procedures. His work centers on identifying and challenging emerging prognostic markers to refine perioperative risk assessment. In his notable 2023 study, Doyle critically evaluated the blood urea nitrogen to serum albumin ratio (BAR)—a parameter gaining attention in other surgical fields—as a predictor of complications following robotic-assisted pulmonary lobectomy. Contrary to prevailing hypotheses, his analysis of patient outcomes demonstrated that a high preoperative BAR does not correlate with worse surgical results, effectively questioning the utility of this biomarker in thoracic surgery. This contribution, already garnering citations, underscores Doyle’s commitment to evidence-based surgical practice and his role in preventing the premature adoption of unvalidated risk stratification tools. By rigorously testing novel prognostic factors, he helps ensure that clinical decisions for lung cancer patients remain grounded in robust, procedure-specific data, advancing the safety and precision of robotic-assisted thoracic surgery.
Research Focus
Key Achievements
Top Papers
- 1